Geode Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $20.3M | Buy |
4,831,657
+288,135
| +6% | +$1.11M | ﹤0.01% | 2147 |
|
|
2026
Q1 | $16M | Buy |
4,543,522
+919,988
| +25% | +$3.77M | ﹤0.01% | 2122 |
|
|
2025
Q4 | $12.2M | Buy |
3,623,534
+8,547
| +0.2% | +$22.2K | ﹤0.01% | 2306 |
|
|
2025
Q3 | $4.74M | Buy |
3,614,987
+115,655
| +3% | +$120K | ﹤0.01% | 2810 |
|
|
2025
Q2 | $2.51M | Buy |
3,499,332
+81,243
| +2% | +$63.8K | ﹤0.01% | 3066 |
|
|
2025
Q1 | $5.03M | Buy |
3,418,089
+111,519
| +3% | +$266K | ﹤0.01% | 2651 |
|
|
2024
Q4 | $14.7M | Buy |
3,306,570
+13,028
| +0.4% | +$52.9K | ﹤0.01% | 2131 |
|
|
2024
Q3 | $13.6M | Sell |
3,293,542
-78,780
| -2% | -$424K | ﹤0.01% | 2193 |
|
|
2024
Q2 | $22M | Buy |
3,372,322
+225,164
| +7% | +$1.59M | ﹤0.01% | 1883 |
|
|
2024
Q1 | $27.4M | Buy |
3,147,158
+66,695
| +2% | +$809K | ﹤0.01% | 1736 |
|
|
2023
Q4 | $35.2M | Buy |
3,080,463
+156,340
| +5% | +$1.55M | ﹤0.01% | 1561 |
|
|
2023
Q3 | $28.2M | Buy |
2,924,123
+131,838
| +5% | +$1.29M | ﹤0.01% | 1599 |
|
|
2023
Q2 | $29.7M | Buy |
2,792,285
+158,481
| +6% | +$1.7M | ﹤0.01% | 1594 |
|
|
2023
Q1 | $27.7M | Buy |
2,633,804
+118,514
| +5% | +$1.33M | ﹤0.01% | 1585 |
|
|
2022
Q4 | $31.2M | Buy |
2,515,290
+49,663
| +2% | +$563K | ﹤0.01% | 1476 |
|
|
2022
Q3 | $25.5M | Sell |
2,465,627
-149,412
| -6% | -$1.69M | ﹤0.01% | 1558 |
|
|
2022
Q2 | $30.2M | Sell |
2,615,039
-143,697
| -5% | -$1.69M | ﹤0.01% | 1474 |
|
|
2022
Q1 | $34.7M | Sell |
2,758,736
-4,832
| -0.2% | -$55.4K | ﹤0.01% | 1511 |
|
|
2021
Q4 | $32.2M | Sell |
2,763,568
-47,836
| -2% | -$587K | ﹤0.01% | 1637 |
|
|
2021
Q3 | $36.7M | Buy |
2,811,404
+53,995
| +2% | +$698K | ﹤0.01% | 1529 |
|
|
2021
Q2 | $35.5M | Sell |
2,757,409
-18,934
| -0.7% | -$217K | ﹤0.01% | 1589 |
|
|
2021
Q1 | $31M | Buy |
2,776,343
+302,099
| +12% | +$3.19M | ﹤0.01% | 1580 |
|
|
2020
Q4 | $28.2M | Buy |
2,474,244
+116,777
| +5% | +$1.28M | ﹤0.01% | 1500 |
|
|
2020
Q3 | $21.2M | Sell |
2,357,467
-59,610
| -2% | -$592K | ﹤0.01% | 1502 |
|
|
2020
Q2 | $24.9M | Buy |
2,417,077
+124,431
| +5% | +$1.27M | 0.01% | 1339 |
|
|
2020
Q1 | $23.1M | Buy |
2,292,646
+98,558
| +4% | +$1.16M | 0.01% | 1207 |
|
|
2019
Q4 | $29.2M | Buy |
2,194,088
+33,084
| +2% | +$365K | 0.01% | 1303 |
|
|
2019
Q3 | $18.6M | Buy |
2,161,004
+36,904
| +2% | +$359K | ﹤0.01% | 1539 |
|
|
2019
Q2 | $23.2M | Sell |
2,124,100
-194,623
| -8% | -$2.18M | 0.01% | 1386 |
|
|
2019
Q1 | $26.3M | Buy |
2,318,723
+338,171
| +17% | +$3.78M | 0.01% | 1238 |
|
|
2018
Q4 | $17.2M | Buy |
1,980,552
+112,777
| +6% | +$1.29M | 0.01% | 1389 |
|
|
2018
Q3 | $28.9M | Buy |
1,867,775
+167,767
| +10% | +$2.65M | 0.01% | 1151 |
|
|
2018
Q2 | $27.2M | Buy |
1,700,008
+168,442
| +11% | +$2.49M | 0.01% | 1127 |
|
|
2018
Q1 | $19.8M | Buy |
1,531,566
+51,118
| +3% | +$637K | 0.01% | 1269 |
|
|
2017
Q4 | $18.6M | Buy |
1,480,448
+36,896
| +3% | +$482K | 0.01% | 1311 |
|
|
2017
Q3 | $19.1M | Buy |
1,443,552
+16,769
| +1% | +$231K | 0.01% | 1278 |
|
|
2017
Q2 | $22.6M | Buy |
1,426,783
+54,632
| +4% | +$794K | 0.01% | 1088 |
|
|
2017
Q1 | $19.6M | Buy |
1,372,151
+127,773
| +10% | +$1.75M | 0.01% | 1162 |
|
|
2016
Q4 | $15.9M | Buy |
1,244,378
+64,865
| +5% | +$819K | 0.01% | 1260 |
|
|
2016
Q3 | $15.7M | Buy |
1,179,513
+40,398
| +4% | +$472K | 0.01% | 1176 |
|
|
2016
Q2 | $12.5M | Buy |
1,139,115
+25,437
| +2% | +$249K | 0.01% | 1268 |
|
|
2016
Q1 | $10.2K | Buy |
1,113,678
+69,425
| +7% | +$573K | 0.01% | 1383 |
|
|
2015
Q4 | $10.1M | Buy |
1,044,253
+54,640
| +6% | +$528K | 0.01% | 1378 |
|
|
2015
Q3 | $8.64M | Buy |
989,613
+69,929
| +8% | +$653K | 0.01% | 1441 |
|
|
2015
Q2 | $9.29M | Buy |
919,684
+18,639
| +2% | +$217K | 0.01% | 1461 |
|
|
2015
Q1 | $12.1M | Buy |
901,045
+46,277
| +5% | +$607K | 0.01% | 1243 |
|
|
2014
Q4 | $11M | Buy |
854,768
+20,951
| +3% | +$240K | 0.01% | 1253 |
|
|
2014
Q3 | $9.05M | Buy |
833,817
+8,199
| +1% | +$93.9K | 0.01% | 1348 |
|
|
2014
Q2 | $10.6M | Buy |
825,618
+33,890
| +4% | +$369K | 0.01% | 1261 |
|
|
2014
Q1 | $8.17M | Buy |
791,728
+178,179
| +29% | +$2M | 0.01% | 1399 |
|
|
2013
Q4 | $5.96M | Buy |
613,549
+55,568
| +10% | +$499K | ﹤0.01% | 1567 |
|
|
2013
Q3 | $5.54M | Buy |
557,981
+67,993
| +14% | +$667K | ﹤0.01% | 1487 |
|
|
2013
Q2 | $4.08M | Buy |
+489,988
| New | +$5.94M | ﹤0.01% | 1560 |
|
Other funds holding IRWD
AC
SCM
Geode Capital Management's IRWD Position: Q2 2026 in Review
Geode Capital Management increased its Ironwood Pharmaceuticals (IRWD) stake by 6.3% in Q2 2026, buying an estimated $1.11M and bringing the position to 4,831,657 shares worth $20.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2147.
Geode Capital Management first reported a position in IRWD in Q2 2013 and has held it in 53 quarters since. The position peaked at $36.7M in Q3 2021. 211 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.
- Geode Capital Management held 4,831,657 shares of Ironwood Pharmaceuticals worth $20.3M as of Q2 2026.
- Geode Capital Management bought 288,135 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $1.11M.
- Ironwood Pharmaceuticals made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2147 holding.
- Geode Capital Management first reported a position in Ironwood Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Geode Capital Management's Ironwood Pharmaceuticals position peaked at $36.7M in Q3 2021.
- 211 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.
Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.